Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000573398 | SCV000666067 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000573398 | SCV000913117 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001403382 | SCV001605252 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-04-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000980173 | SCV001889217 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004802214 | SCV005424310 | likely benign | BRCA2-related cancer predisposition | 2024-08-06 | criteria provided, single submitter | clinical testing |